⌘K
Loading ticker…
As of 2026-08-25, Humacyte, Inc. Common Stock (HUMA) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.9%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
HUMA is in a stage 4 downtrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.2% / -27.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
HUMA is held by 15 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $3M.
Held by 27 ETFs · $12M across latest filings · largest weight 0.05% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $947K | — |
| VHTVanguard Health Care ETF | 0.00% | $617K | — |
| VTWV | 0.01% | $126K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $90K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| VTWG | 0.00% | $47K | — |
| IBBQ | 0.02% | $13K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $13K | — |
| ITWO | 0.01% | $10K | — |
| BIB | 0.01% | $9K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HUMA Jan avg: 9.03% median: 10.39% win: 75% σ: 14.93% n: 4 2022-04-12 → 2026-07-31 | HUMA Feb avg: 8.34% median: 14.05% win: 75% σ: 24.18% n: 4 2022-04-12 → 2026-07-31 | HUMA Mar avg: -30.74% median: -37.05% win: 25% σ: 23.07% n: 4 2022-04-12 → 2026-07-31 | HUMA Apr avg: 12.49% median: 7.76% win: 80% σ: 20.66% n: 5 2022-04-12 → 2026-07-31 | HUMA May avg: 42.39% median: 54.43% win: 80% σ: 49.71% n: 5 2022-04-12 → 2026-07-31 | HUMA Jun avg: -31.00% median: -35.83% win: 0% σ: 11.12% n: 5 2022-04-12 → 2026-07-31 | HUMA Jul avg: 23.75% median: 14.69% win: 80% σ: 42.94% n: 5 2022-04-12 → 2026-07-31 | HUMA Aug avg: -12.45% median: -15.27% win: 50% σ: 27.32% n: 4 2022-04-12 → 2026-07-31 (current) | HUMA Sep avg: -8.00% median: -10.38% win: 25% σ: 14.86% n: 4 2022-04-12 → 2026-07-31 | HUMA Oct avg: -8.29% median: -5.60% win: 25% σ: 14.01% n: 4 2022-04-12 → 2026-07-31 | HUMA Nov avg: -3.52% median: -9.96% win: 25% σ: 19.51% n: 4 2022-04-12 → 2026-07-31 | HUMA Dec avg: -10.58% median: -10.84% win: 50% σ: 23.25% n: 4 2022-04-12 → 2026-07-31 |